يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Obrador, T"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Организация KDIGO выражает свою благодарность спонсорам, которые дают возможность реализовать наши инициативы: Abbott, Amgen, Belo Foundation, Coca-Cola Company, Dole Food Company, Genzyme, HoffmannLaRoche, JC Penney, NATCO – the Organization for Transplant Professionals (Профессиональная организация трансплантологов), National Kidney Foundation – Board of Directors (Совет директо ров), Novartis, Robert and Jane Cizik Foundation, Shire, Transwestern Commercial review BL Kasiske : KDIGO guideline for kidney transplant recipients Services, Wyeth. Организация KDIGO поддерживается консорциумом спонсоров, и для разработки конкретных рекомендаций никакие иные формы финансирования не принимаются.

    المصدر: Transplantologiya. The Russian Journal of Transplantation; № 2 (2010); 38-52 ; Трансплантология; № 2 (2010); 38-52 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-2

    وصف الملف: application/pdf

    العلاقة: https://www.jtransplantologiya.ru/jour/article/view/282/345Test; Kasiske B.L., Vazquez M.A., Harmon W.E. et al. Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 2000;11:1–86.; European Best Practice Guidelines Expert Group on Renal Transplantation. Section IV: long-term management of the transplant recipient. Nephrol Dial Transplant 2002;17(Suppl 4):1–67.; Eckardt K.U., Kasiske B. Kidney Disease: Improving Global Outcomes (KDIGO). Nat Rev Nephrol (in revision).; Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9(Suppl 3):1–157.; Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int 2008;73(Suppl 109):1–99.; Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease – mineral and bone disorder (CKD–MBD). Kidney Int 2009;76(Suppl 113):1–130.; Agency for Healthcare Research and Quality. Methods Reference Guide for Effectiveness and Comparative Effectiveness Reviews, version 1.0. Agency for Healthcare Research and Quality, US Department of Health and Human Services: Rockville, MD, 2007.; Atkins D., Best D., Briss P.A. et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490–4.; Uhlig K., Macleod A., Craig J. et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;70:2058–65.; Guyatt G.H., Oxman A.D., Kunz R. et al. Going from evidence to recommendations. BMJ 2008;336:1049–51.; https://www.jtransplantologiya.ru/jour/article/view/282Test

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Studies in Health Technology & Informatics; 2009, Vol. 142, p201-203, 3p